RVMDW Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $11.41
Market Cap (MRQ) $2.44B
P/E -1.9
EPS $-5.95
Revenue $0
ROE -64.7%
52W Range $1–$13

RVMDW Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

About Revolution Medicines, Inc. - Warrant Company overview from Wikipedia

05 · wikidata
sector· industry· employees883

10-Year Performance Revenue, net income, margins and EPS trends

06
Revenue$0
2018-12-31 → 2025-12-31
EPS$-5.95
2020-12-31 → 2025-12-31
Free Cash Flow$-914M
2020-12-31 → 2025-12-31
Net margin·
2020-12-31 → 2023-12-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend RVMDW 5Y avg Peer Median Verdict
P/E -1.9 · · ·
P/B (MRQ) 0.9 · · ·
Price / FCF (TTM) -2.0 · · ·
Price / Cash Flow (TTM) -2.0 · · ·
Price / Tangible Book (MRQ) 1.0 · · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 16
Metric Trend 2025202420232022202120202019
Revenue $0$0$12M$35M$29M$43M$50M
R&D Expense $987M$592M$423M$253M$187M$132M$92M
SG&A Expense $195M$97M$76M$41M$30M$21M$12M
Operating Expenses $1.18B$690M$499M$294M$217M$154M$104M
Operating Income $-1.18B$-690M$-487M$-258M$-188M$-111M$-54M
Interest Expense ···$0$12.0K$71.0K$106.0K
Interest Income $91M$87M$47M$9M$929.0K$2M$2M
Other Non-op $51M$89M$47M$9M$917.0K$2M$2M
Pretax Income $-1.13B$-601M$-440M$-249M$-187M$-109M$-52M
Income Tax $0$-753.0K$-4M$-420.0K$0$-371.0K$-4M
Net Income $-1.13B$-600M$-436M$-249M$-187M$-108M$-48M
EPS (Basic) $-5.95$-3.58$-3.86$-3.08$-2.57$-2.01·
EPS (Diluted) $-5.95$-3.58$-3.86$-3.08$-2.57$-2.01·
Shares (Basic) 190,129,154167,737,672113,149,86980,626,52572,806,07954,874,119·
Shares (Diluted) 190,129,154167,737,672113,149,86980,626,52572,806,07954,874,119·
EBITDA $-1.17B$-683M$-487M$-254M$-185M$-108M·
Balance Sheet 24
Metric Trend 2025202420232022202120202019
Cash & Equivalents $384M$543M$696M$161M$108M$104M$17M
Short-term Investments $1.64B$1.75B$1.16B$484M$469M$336M$106M
Prepaid Expense $49M$38M$25M$11M$7M$7M$2M
Current Assets $2.08B$2.33B$1.88B$660M$590M$454M$134M
PP&E (Net) $33M$24M$23M$19M$12M$9M$7M
PP&E (Gross) $62M$46M$41M$33M$22M$17M$13M
Accum. Depreciation $29M$22M$18M$14M$11M$8M$6M
Goodwill $15M$15M$15M$15M$15M$15M$15M
Intangibles $56M$57M$58M$59M$60M$61M$62M
Other Non-current Assets $15M$2M$7M$3M$758.0K$305.0K$3M
Total Assets $2.35B$2.56B$2.06B$812M$738M$567M$221M
Accounts Payable $65M$54M$62M$21M$14M$13M$11M
Accrued Liabilities $5M······
Current Liabilities $290M$164M$144M$62M$60M$47M$43M
Capital Leases $142M$123M$81M$57M$60M$29M·
Deferred Tax $2M$2M$3M$7M$7M$7M$8M
Other Non-current Liabilities $1M$670.0K$1M$301.0K$634.0K$632.0K$655.0K
Total Liabilities $723M$293M$236M$127M$135M$93M$68M
Common Stock $19.0K$18.0K$16.0K$9.0K$8.0K$7.0K·
Retained Earnings $-2.87B$-1.74B$-1.14B$-701M$-453M$-266M$-157M
AOCI $3M$1M$544.0K$-2M$-376.0K$116.0K$74.0K
Stockholders' Equity $1.63B$2.27B$1.83B$685M$603M$475M$-153M
Liabilities + Equity $2.35B$2.56B$2.06B$812M$738M$567M$221M
Shares Outstanding 197,001,401185,896,625164,674,59490,411,91274,142,61966,599,7483,292,124
Cash Flow 15
Metric Trend 2025202420232022202120202019
D&A $8M$7M$5M$4M$3M$3M$2M
Stock-based Comp $118M$79M$62M$31M$21M$9M$3M
Deferred Tax $0$-738.0K$-4M$-420.0K···
Amort. of Intangibles $870.0K$1M$1M$1M$1M$1M$1M
Other Non-cash $107M$-42M·$-11M$16M$-3M·
Operating Cash Flow $-898M$-557M$-351M$-224M$-147M$-100M$-50M
CapEx $16M$10M$8M$11M$7M$3M$3M
Investing Cash Flow $118M$-554M$-343M$-24M$-142M$-234M$-102M
Stock Issued $0$728M$324M$248M$281M$420M·
Net Stock Activity $0$728M$324M$248M$281M$420M·
Dividends Paid ·····$0·
Financing Cash Flow $622M$959M$1.23B$301M$294M$423M$99M
Net Change in Cash $-158M$-152M$536M$53M$5M$88M$-53M
Free Cash Flow $-914M$-568M$-358M$-235M$-154M$-103M·
Levered FCF ···$-235M$-154M$-103M·
Profitability 7
Metric Trend 2025202420232022202120202019
Operating Margin ··-4207.1%-730.0%-639.7%-257.5%·
Net Margin ··-3768.3%-702.9%-636.6%-251.6%·
Pretax Margin ··-3798.7%-704.1%-636.6%-252.5%·
EBITDA Margin ··-4207.1%-718.8%-629.2%-251.5%·
ROA -46.1%-26.0%-30.4%-32.1%-28.7%-27.5%·
ROE -64.7%-31.3%-32.8%-36.4%-30.2%-22.1%·
ROIC -72.5%-30.4%-26.5%-37.6%-31.2%-23.2%·
Liquidity & Solvency 3
Metric Trend 2025202420232022202120202019
Current Ratio 7.114.213.110.79.89.6·
Quick Ratio 7.014.012.910.49.69.3·
Interest Coverage ····-15667.3-1559.1·
Efficiency 1
Metric Trend 2025202420232022202120202019
Asset Turnover 0.00.00.00.00.00.1·
Per Share 5
Metric Trend 2025202420232022202120202019
Book Value / Share $8.28$12.19$11.09$7.58$8.13$7.13·
Revenue / Share $0.00$0.00$0.10$0.44···
Cash Flow / Share $-4.72$-3.32$-3.10$-2.78···
Cash / Share $1.95$2.92$4.23$1.79$1.46$1.57·
EPS (TTM) $-5.95$-3.58$-3.86$-3.08$-2.57$-2.01·
Growth Rates 2
Metric Trend 2025202420232022202120202019
Revenue YoY ··-67.3%20.4%-31.6%··
Revenue CAGR 3Y ··-35.4%····
Valuation (TTM) 11
Metric Trend 2025202420232022202120202019
Revenue TTM $0$0$12M$35M$29M$43M$50M
Net Income TTM $-1.13B$-600M$-436M$-249M$-187M$-108M$-48M
Market Cap $158M······
P/E -0.1······
P/B 0.1······
P / Tangible Book 0.1······
P / Cash Flow -0.2······
P / FCF -0.2······
Earnings Yield -742.7%······
Payout Ratio ·····0.00%·
Annual Payout ·····$0·

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $0 $0 $12M $35M $29M
Operating Margin % · · -4207.1% -730.0% -639.7%
Net Income $-1.13B $-600M $-436M $-249M $-187M
Diluted EPS $-5.95 $-3.58 $-3.86 $-3.08 $-2.57

Institutional owners (13F) 23 filers · $99.7M total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 23
Value held $99.7M
New positions 5
Exited positions 3
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
5 (+3 vs prior Q) 3 (-1 vs prior Q) 4 (-1 vs prior Q) 2 (-4 vs prior Q) +1.3M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
LMR Partners LLP $47,524,183 5,066,598 47.67% Shares
D. E. Shaw & Co., Inc. $14,855,243 1,580,345 14.90% Shares
Sculptor Capital LP $6,656,634 709,670 6.68% Shares
CSS LLC/IL $6,610,382 78,367 6.63% Shares
Caption Management, LLC $4,855,834 517,685 4.87% Shares
ADAGE CAPITAL PARTNERS GP, L.L.C. $4,689,950 500,000 4.70% Shares
Rangeley Capital, LLC $4,682,000 25,000 4.70% Shares
PERCEPTIVE ADVISORS LLC $2,344,975 250,000 2.35% Shares
Bleichroeder LP $1,875,980 200,000 1.88% Shares
WOLVERINE ASSET MANAGEMENT LLC $1,449,607 154,544 1.45% Shares
FARALLON CAPITAL MANAGEMENT, L.L.C. $1,128,799 120,085 1.13% Shares
Warberg Asset Management LLC $889,186 94,797 0.89% Shares
MILLENNIUM MANAGEMENT LLC $814,438 86,828 0.82% Call option
Weiss Asset Management LP $692,216 73,640 0.69% Shares
TD Asset Management Inc $381,978 40,636 0.38% Shares
Driehaus Capital Management LLC $188,000 20,000 0.19% Shares
UBS Group AG $23,084 2,461 0.02% Shares
MORGAN STANLEY $20,786 2,216 0.02% Shares
DLK Investment Management, LLC $7,862 77,000 0.01% Shares
PRICE T ROWE ASSOCIATES INC /MD/ $5,448 579,550 0.01% Shares
TD Waterhouse Canada Inc. $4,118 448 0.00% Shares
ROYAL BANK OF CANADA $2,000 200 0.00% Shares
OSAIC HOLDINGS, INC. $562 60 0.00% Shares

Company insiders 14 insiders · 7 officers · 8 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Stephen Michael Kelsey Senior Advisor to the Chief Executive Officer Sept. 16, 2026 S 286,307 0 3 $-1,761,338
Mark A Goldsmith President and Chief Executive Officer Sept. 16, 2026 S 253,342 0 21 $-22,342,258
Jack Anders Chief Financial Officer Sept. 16, 2026 S 119,216 0 7 $-4,599,057
Margaret A Horn Chief Operating Officer Sept. 16, 2026 S 149,680 0 12 $-17,441,669
Anthony Mancini Chief Global Commercialization Officer Sept. 25, 2026 M 39,765 0 11 $-5,318,424
Jeff Cislini SVP & General Counsel Sept. 16, 2026 S 52,541 0 9 $-12,911,646
Alan B. Sandler Chief Development Officer Sept. 16, 2026 S 52,868 0 2 $-67,940
Elizabeth M Anderson Director Sept. 22, 2026 M 4,333 0 5 $-1,958,025
Lorence H. Kim Director Sept. 8, 2026 S 0 0 14 $-14,967,102
Sushil Patel Director June 29, 2026 M 21,656 0 9 $-1,048,970
Flavia Borellini Director June 18, 2026 A 26,215 0 0 $0
Frank Clyburn Director June 18, 2026 A 10,929 0 0 $0
Sandra Horning Director June 18, 2026 A 97,765 0 0 $0
Alexis Borisy Director June 18, 2026 A 2,340,075 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed Aug 5, 2026